BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 46 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $336,000 | -9.4% | 150,166 | 0.0% | 0.17% | -3.9% |
| Q3 2014 | $371,000 | -10.8% | 150,166 | +2.8% | 0.18% | -11.9% |
| Q2 2014 | $416,000 | -22.7% | 146,016 | +65.8% | 0.20% | -23.2% |
| Q1 2014 | $538,000 | +45.8% | 88,089 | 0.0% | 0.26% | +49.4% |
| Q4 2013 | $369,000 | +41.9% | 88,089 | +41.9% | 0.18% | +22.2% |
| Q3 2013 | $260,000 | +152.4% | 62,089 | +107.4% | 0.14% | +140.0% |
| Q2 2013 | $103,000 | – | 29,935 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,617,500 | $3,348,000 | 0.58% |
| Broadfin Capital, LLC | 2,611,711 | $5,406,000 | 0.29% |
| RA Capital Management | 807,855 | $1,672,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $331,000 | 0.16% |
| BVF INC/IL | 350,776 | $726,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $606,000 | 0.09% |
| Koshinski Asset Management, Inc. | 27,200 | $28,180,000 | 0.02% |
| Baker Brothers Advisors | 830,440 | $1,719,000 | 0.02% |
| KNOTT DAVID M | 31,833 | $65,894,000 | 0.01% |
| SHEPHERD KAPLAN KROCHUK, LLC | 26,756 | $55,000 | 0.01% |